Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4596619011 | Acetic acid 9 mg/g and oxyquinoline (as oxyquinoline sulfate) 250 microgram/g vaginal gel | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4596620017 | Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Has concentration strength numerator value | 250 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Has basis of strength substance | Acetic acid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Has concentration strength numerator value | 9 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Has concentration strength denominator unit | milligram | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Has concentration strength numerator unit | microgram | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Has concentration strength denominator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Has concentration strength numerator unit | nanogram | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Has basis of strength substance | Oxyquinoline | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Has manufactured dose form | Conventional release vaginal gel | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Has precise active ingredient | Oxyquinoline sulfate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Has precise active ingredient | Acetic acid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Is a | Product containing only acetic acid and oxyquinoline in vaginal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Plays role | Antifungal therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Plays role | Antiprotozoal therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Has concentration strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely acetic acid 9 milligram/1 gram and oxyquinoline (as oxyquinoline sulfate) 250 microgram/1 gram conventional release vaginal gel (clinical drug) | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR